The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 2,365 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
| ALTRIA GROUP INC | COM | 02209S103 | 2,318 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| AQUABOUNTY TECHNOLOGIES INC | COM NEW | 03842K200 | 81,778 | 18,253,912 | SH | SOLE | 18,253,912 | 0 | 0 | ||
| CHEVRON CORP NEW | COM | 166764100 | 2,088 | 29,000 | SH | SOLE | 29,000 | 0 | 0 | ||
| EMERGENT BIOSOLUTIONS INC | COM | 29089Q105 | 394 | 3,810 | SH | SOLE | 3,810 | 0 | 0 | ||
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | 78,539 | 2,988,532 | SH | SOLE | 2,988,532 | 0 | 0 | ||
| KINDER MORGAN INC DEL | COM | 49456B101 | 2,219 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| LGI HOMES INC | COM | 50187T106 | 209 | 1,800 | SH | SOLE | 1,800 | 0 | 0 | ||
| ORAGENICS INC | COM PAR | 684023302 | 2,652 | 4,612,166 | SH | SOLE | 4,612,166 | 0 | 0 | ||
| PNC FINL SVCS GROUP INC | COM | 693475105 | 2,638 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
| PRECIGEN INC | COM | 74017N105 | 294,075 | 84,021,428 | SH | SOLE | 84,021,428 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 11,962 | 255,873 | SH | SOLE | 255,873 | 0 | 0 | ||
| QUAKER CHEM CORP | COM | 747316107 | 232 | 1,290 | SH | SOLE | 1,290 | 0 | 0 | ||
| TC PIPELINES LP | UT COM LTD PRT | 87233Q108 | 1,631 | 63,752 | SH | SOLE | 63,752 | 0 | 0 | ||